ArticleThe Biochemical journal1991
Characterization of a mastoparan-stimulated nucleotidase from bovine brain.
Article in The Biochemical journal, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
- How do basic secretagogues activate mast cells?Naunyn-Schmiedeberg's archives of pharmacology · 2015Article
- Mastoparan may activate GTP hydrolysis by Gi-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase.The Biochemical journal · 1994Article
- Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells.British journal of pharmacology · 1994Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Mastoparan is a 14-amino-acid peptide that stimulates secretion from several cell types. Secretion can be partially blocked by pertussis toxin and may be mediated by guanine-nucleotide-binding proteins (G-proteins). Mastoparan can act directly on G-proteins, probably at the hormone receptor-binding site, to stimulate guanosine 5'-[gamma-thio]triphosphate binding and GTPase activities of pertussis-toxin substrates Go and Gi [Higashijima, Uzu, Nakajima & Ross (1988) J. Biol. Chem. 263, 6491-6494]. We now describe a nucleotidase from bovine brain that is not a known G-protein whose GTPase and ATPase activities are stimulated by mastoparan. This nucleotidase hydrolyses ATP faster than GTP, but has similar affinities for both (0.4 microM). Mastoparan maximally stimulates both ATPase and GTPase activities by about 8-fold after insertion of the protein into phospholipid vesicles, but does not affect the EC50 (concentration at which half the maximal effect is observed) for ATP and GTP. The EC50 for mastoparan stimulation of GTPase and ATPase is 6 and 12 microM respectively. The native molecular mass of the partially purified mastoparan-stimulated nucleotidase is 87 kDa. This nucleotidase may be another receptor-activated enzyme, and its identification may be useful for understanding mastoparan-stimulated processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.